Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020
Operating activities
Net income	$ 1,542	$ (2,070)	$ 4,496	$ 3,280
Adjustments to reconcile net income to net cash provided by operating activities
Loss on disposal of property & equipment			123
Depreciation	495	722	1,609	2,160
Amortization of internal-use software	267	521	1,077	1,490
Deferred income taxes			(491)	(499)
Share-based compensation	3,839	6,630	10,802	9,312
Changes in operating assets and liabilities			4,199	(659)
Net cash provided by operating activities			21,815	15,084
Investing activities
Capital expenditures			(1,078)	(1,076)
Additional investments in corporate-owned life insurance policies			(3)	(2)
Net cash used in investing activities			(1,081)	(1,078)
Financing activities
Repurchase of common shares to satisfy employee tax withholding			(2,902)	(1,069)
Series A convertible preferred stock issuance proceeds, net of issuance costs				33,969
Payment of preferred stock dividends			(1,836)	(1,117)
Principal payments under long-term obligations			(16)	(18)
Net cash (used in) provided by financing activities			(4,754)	31,765
Effect of exchange rate changes on cash			(38)	184
Net increase in cash and cash equivalents			15,942	45,955
Cash and cash equivalents at beginning of period			99,180	46,653
Cash and cash equivalents at end of period	$ 115,122	$ 92,608	$ 115,122	$ 92,608